ISPOR 17th Annual International Meeting
June 2-6, 2012, Washington, DC, USA
Search:
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
Médicaments Issus des Biotechnologies : Différencier Les Prix selon la Valeur
Comments on : Performance-Based Risk-Sharing Arrangements - Good practice for design, implementation and evaluation. An ISPOR Task force review
EUnetHTA : Draft Guidelines - Endpoints used for REA of pharmaceuticals HEALTH-RELATED QUALITY OF LIFE and UTILITY MEASURES
Home
Links
Cyberhealth
Collapse all
|
Expand all
|
Plus links
e-books
e-ethics
e-material
e-patient (Associations de patients)
e-portal : Business to Business (b to b)
e-portal : Business to Consumer (b to c)
e-quality
e-sales
e-trials
Value-based Decision Making in Rheumatic Disease : What does it mean for pharmacists ?
